Member Info for bamb

Tick up now

Translation - Bluebay hasn't got enough shares

We won't be down here though for 2-3 weeks. By mid August everyone will be buying here.

We are a damn lot closer than we were back then to success. SP should be 4-5p right now

Try again....will be 3p before RNS and 10p sharpish

More like 10p with good EWT

This is going to be a t/o very soon 💰💰💰💰

This isn't about GDR

Some big buys too :)

What delay?

Obvious some people know contract in the bag....what are we looking at when the RNS drops...is 10p realistic?

Follow the money here. Another TR1 due?

Don't think they haven't been lining up deals pre NICE recommendation....first one could come sooner than some think

Ssshhhhhh...i haven't finished buying yet

Classic drop again....20mn market cap way too low (even without deals)

Don't talk blx gloria

Not difficult...

https://www.thisismoney.co.uk/money/markets/article-13694629/MARKET-REPORT-City-duo-team-inject-20bn-UK-start-ups.html?ico=mol_desktop_moneymarkets-newtab&molReferrerUrl=https%3A%2F%2Fwww.dailymail.co.uk%2Fmoney%2Fmarkets%2Findex.html&_gl=1*t8yqy9*_ga*MTcxMTkzMTYzNy4xNzIwMDgwMzky*_ga_C9F47K6NW6*MTcyMjQ5ODE0Ny4zLjEuMTcyMjQ5ODE0OS41OC4wLjE1NzcwMjIwNjY.*_ga_GQE6MT7DLZ*MTcyMjQ5ODE0Ny4zLjEuMTcyMjQ5ODE0OS4wLjAuMA..

Genedrive secured a recommendation from the National Institute for Health and Care Excellence (NICE).

NICE agreed that the company’s test kits should be used to guide Clopidogrel drug use after an ischaemic stroke or transient ischaemic attack and be the test of choice for point-of-care strategies.

The ID test uses a non-invasive cheek swab, which helps clinicians optimise treatment plans for stroke patients.

Genedrive shares jumped 8.6 per cent, or 0.33p, to 4.13p.

Salm, are you slacker on the GDR board?

Suggest we all cross ramp on POLX board

Must be a few of them on here this morning lol